Network origin in Martin Busch first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
AaviGen GmbH
 AaviGen GmbH BiotechnologyHealth Technology AaviGen GmbH is a German pre-clinical biotechnology company that focuses on developing curative gene therapies. The company is based in Heidelberg, Germany. AaviGen was founded by Martin Busch, Marc Lerchenmueller, Hugo Katus, and Patrick Most. Patrick Most has been the CEO since incorporation.
3
| Holding Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martin Busch via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
uniQure GmbH
 uniQure GmbH BiotechnologyHealth Technology Part of uniQure NV, uniQure GmbH is a German company that provides research and development services of human gene-based therapies. The company is based in Heidelberg, Germany. The company was founded by Hugo Katus, Patrick Most. uniQure was acquired by uniQure NV on August 11, 2014 for $4.02 million. | Biotechnology | Founder Founder |
Statistics
International
| Germany | 2 |
Sectoral
| Health Technology | 2 |
Operational
| Founder | 5 |
| Chief Executive Officer | 1 |
| Sales & Marketing | 1 |
| Director of Finance/CFO | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Patrick Most | 2 |
| Hugo Katus | 2 |
| Marc Lerchenmueller | 1 |
- Stock Market
- Insiders
- Martin Busch
- Company connections
